/PRNewswire/ Lannett Company, Inc. (NYSE: LCI) today announced that it has entered into an agreement with Areva Pharmaceuticals to be the exclusive U.S..
Lannett Company, Inc. (NYSE:NYSE:LCI) Q3 2022 Earnings Conference Call May 4, 2022 4:30 PM ET Company Participants Robert Jaffe - Investor Relations, Robert Jaffe Co., LLC Timothy Crew -.
/PRNewswire/ Lannett Company, Inc. (NYSE: LCI) today announced that it has initiated the pivotal clinical trial of biosimilar insulin glargine, a product.